Farid Ramy
SEC CIK 1797707 · EDGAR
BoughtSold
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
| 11 | Farid Ramy | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-28 19:24 | 2026-05-27 | VIR | Vir Biotechnology, Inc. | Farid Ramy | Dir | A - Grant | $0.00 | +8,000 | 32.0K | +33% | $0 |
| DMT | 2026-04-17 18:09 | 2026-04-16+ | SDGR | Schrodinger, Inc. | Farid Ramy | Pres, CEO, Dir | M - OptEx | $3.07 | +160.5K | 405.4K | +66% | +$492.8K |
| DMT | 2026-04-17 18:09 | 2026-04-16+ | SDGR | Schrodinger, Inc. | Farid Ramy | Pres, CEO, Dir | S - Sale+OE | $12.27 | -86.0K | 330.8K | -21% | -$1.06M |
| 2026-03-06 | 2026-03-05 | SDGR | Schrodinger, Inc. | Farid Ramy | Pres, CEO, Dir | S - Sale | $12.91 | -3,661 | 330.8K | -1% | -$47.3K | |
| DM | 2026-03-03 | 2026-03-02 | SDGR | Schrodinger, Inc. | Farid Ramy | Pres, CEO, Dir | A - Grant | $0.00 | +118.1K | 291.8K | +68% | $0 |
| D | 2026-03-03 | 2026-03-02 | SDGR | Schrodinger, Inc. | Farid Ramy | Pres, CEO, Dir | S - Sale | $11.90 | -5,560 | 334.5K | -2% | -$66.2K |
| D | 2025-06-02 | 2025-05-30 | VIR | Vir Biotechnology, Inc. | Farid Ramy | Dir | A - Grant | $0.00 | +8,000 | 24.0K | +50% | $0 |
| D | 2025-03-04 | 2025-03-03 | SDGR | Schrodinger, Inc. | Farid Ramy | Pres, CEO, Dir | A - Grant | $0.00 | +37.5K | 221.9K | +20% | $0 |
| D | 2024-05-31 | 2024-05-29 | VIR | Vir Biotechnology, Inc. | Farid Ramy | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
| DI | 2023-02-09 | 2023-02-07 | GPCR | Structure Therapeutics Inc. | Farid Ramy | Dir | C - Cnv Deriv | — | +642.2K | 3.26M | +25% | — |
| D | 2023-01-05 | 2023-01-04 | SDGR | Schrodinger, Inc. | Farid Ramy | Pres, CEO, Dir | S - Sale+OE | $18.28 | -66.9K | 184.4K | -27% | -$1.22M |
| D | 2023-01-05 | 2023-01-04 | SDGR | Schrodinger, Inc. | Farid Ramy | Pres, CEO, Dir | M - OptEx | $1.20 | +66.9K | 251.3K | +36% | +$80.3K |
Purchase Sale Sale after option exercise All abbreviations